Skip to main content

Nassim Usma, Paul M. Meister

Premium
RXi Pharmaceuticals this week announced that Nassim Usman has joined its scientific advisory board. Usman is currently CEO and a director of Catalyst Biosciences. Prior to joining Catalyst, he was an entrepreneur-in-residence at Morgenthaler Ventures.
 
Usman previously held several positions during his 13-year tenure at Sirna. Usman is currently a member of the scientific advisory board of Noxxon Pharma.
 

 
Thermo Fisher Scientific this week announced that Paul M. Meister, chairman of the board and former vice chairman of Fisher Scientific International, decided to retire from the company’s board of directors. 
 
The company also announced that Meister has relinquished his position as chairman of the board.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.